Her2 is a member of the epidermal growth factor receptor (EGFR) family, commonly known as a tumor antigen over-expressed in 20 to 30% of breast cancers, but also expressed in many other cancer types [17]. This evidence concerns the gene EGFR and breast carcinoma.